Reference
Karasawa Y, et al. Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan PLOS One : 6 Jul 2021. Available from: URL: https://doi.org/10.1371/journal.pone.0253547
Rights and permissions
About this article
Cite this article
Authorised generic celecoxib good value in Japan. PharmacoEcon Outcomes News 883, 1 (2021). https://doi.org/10.1007/s40274-021-7872-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7872-z